Ouro Fino Saúde Animal Participações S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 06, 2020 at 06:39 pm
Share
Ouro Fino Saúde Animal Participações S.A. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was BRL 172.535 million compared to BRL 177.726 million a year ago. Operating income was BRL 12.070 million compared to BRL 26.084 million a year ago. Net income was BRL 14.734 million compared to BRL 13.995 million a year ago. Basic earnings per share was BRL 0.27311 compared to BRL 0.25941 a year ago. For the half year, sales was BRL 284.414 million compared to BRL 268.704 million a year ago. Operating income was BRL 12.416 million compared to BRL 21.531 million a year ago. Net income was BRL 12.579 million compared to BRL 8.578 million a year ago. Basic earnings per share was BRL 0.23316 compared to BRL 0.159 a year ago.
Ouro Fino Saude Animal Participacoes S.A., also known as Ourofino, is a Brazil-based company engaged in the animal health market business sector in Latin America. The Company manufactures veterinary products using scientific technology in the Company's laboratories. The Company's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.
OURO FINO SAÚDE ANIMAL PARTICIPAÇÕES S.A. 
